Form D — EQT Life Sciences 8-Core Cooperatief U.A.
0002096488-26-000001 · filed 2026-04-28
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.1, 3C.7
- Total offering
- —
- Total sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- EQT Life Sciences 8-Core Cooperatief U.A.
- CIK
- 2096488
- Entity
- Other
- Jurisdiction
- NETHERLANDS
- Year incorporated
- 2025
- Address
- JOHANNES VERMEERPLEIN 9
AMSTERDAM, P7 1071 DV - Phone
- 31-20-5776647
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Cillian Robert King · Executive OfficerAmsterdam, P7 Find on LinkedIn ↗
-
Philippus Scheltens · Executive OfficerAmsterdam, P7 Find on LinkedIn ↗
-
Felice Isabel Verduyn-van Weegen · Executive OfficerAmsterdam, P7 Find on LinkedIn ↗
-
Rene Robert Kuijten · Executive OfficerAmsterdam, P7 Find on LinkedIn ↗
-
N/A EQT Life Sciences 8 Director B.V. · PromoterAmsterdam, P7 Find on LinkedIn ↗
View original on SEC EDGAR.